HomeANIP • NASDAQ
add
ANI Pharmaceuticals Inc Common Stock
Previous close
$75.96
Day range
$74.91 - $77.47
Year range
$56.71 - $99.50
Market cap
1.71B USD
Avg Volume
374.85K
P/E ratio
22.95
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 247.06M | 29.64% |
Operating expense | 117.16M | 12.59% |
Net income | 27.49M | 367.52% |
Net profit margin | 11.13 | 306.49% |
Earnings per share | 2.33 | 42.94% |
EBITDA | 52.24M | 104.02% |
Effective tax rate | 12.67% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 294.72M | 94.96% |
Total assets | 1.44B | 12.14% |
Total liabilities | 899.65M | 5.11% |
Total equity | 540.72M | — |
Shares outstanding | 20.88M | — |
Price to book | 2.94 | — |
Return on assets | 5.20% | — |
Return on capital | 6.42% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 27.49M | 367.52% |
Cash from operations | 30.37M | 91.47% |
Cash from investing | -1.40M | 86.86% |
Cash from financing | -4.64M | 5.52% |
Net change in cash | 22.98M | 18,778.86% |
Free cash flow | 16.80M | -1.75% |
About
Founded
2001
Headquarters
Website
Employees
970
